1-12 of 12
Gerjan Navis
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Response to Comment on Oosterwijk et al. High-Normal Protein Intake Is Not Associated With Faster Renal Function Deterioration in Patients With Type 2 Diabetes: A Prospective Analysis in the DIALECT Cohort. Diabetes Care 2022;45:35–41

Free
Milou M. Oosterwijk, Dion Groothof, Gerjan Navis, Stephan J.L. Bakker, Gozewijn D. Laverman
Journal: Diabetes Care
Diabetes Care 2022;45(3):e69
https://doi.org/10.2337/dci21-0062
Published: 04 March 2022
View articletitled, Response to Comment on Oosterwijk et al. High-Normal Protein Intake Is Not Associated With Faster Renal Function Deterioration in Patients With Type 2 Diabetes: A Prospective Analysis in the DIALECT Cohort. Diabetes Care 2022;45:35–41
Open the PDF for Response to Comment on Oosterwijk et al. High-Normal Protein Intake Is Not Associated With Faster Renal Function Deterioration in Patients With Type 2 Diabetes: A Prospective Analysis in the DIALECT Cohort. Diabetes Care 2022;45:35–41 in another window
Journal Articles

High-Normal Protein Intake Is Not Associated With Faster Renal Function Deterioration in Patients With Type 2 Diabetes: A Prospective Analysis in the DIALECT Cohort

Free
Milou M. Oosterwijk, Dion Groothof, Gerjan Navis, Stephan J.L. Bakker, Gozewijn D. Laverman
Journal: Diabetes Care
Diabetes Care 2022;45(1):35–41
https://doi.org/10.2337/dc21-1211
Published: 28 October 2021
View articletitled, High-Normal Protein Intake Is Not Associated With Faster Renal Function Deterioration in Patients With Type 2 Diabetes: A Prospective Analysis in the DIALECT Cohort
Open the PDF for High-Normal Protein Intake Is Not Associated With Faster Renal Function Deterioration in Patients With Type 2 Diabetes: A Prospective Analysis in the DIALECT Cohort in another window
Journal Articles

Glucose Regulation Beyond HbA1c in Type 2 Diabetes Treated With Insulin: Real-World Evidence From the DIALECT-2 Cohort

Free
Niala den Braber, Miriam M.R. Vollenbroek-Hutten, Kathryn M. Westerik, Stephan J.L. Bakker, Gerjan Navis, Bert-Jan F. van Beijnum, Gozewijn D. Laverman
Journal: Diabetes Care
Diabetes Care 2021;44(10):2238–2244
https://doi.org/10.2337/dc20-2241
Published: 22 July 2021
View articletitled, Glucose Regulation Beyond HbA1c in Type 2 Diabetes Treated With Insulin: Real-World Evidence From the DIALECT-2 Cohort
Open the PDF for Glucose Regulation Beyond HbA1c in Type 2 Diabetes Treated With Insulin: Real-World Evidence From the DIALECT-2 Cohort in another window
Journal Articles

Biochemical Urine Testing of Medication Adherence and Its Association With Clinical Markers in an Outpatient Population of Type 2 Diabetes Patients: Analysis in the DIAbetes and LifEstyle Cohort Twente (DIALECT)

Free
Jelle M. Beernink, Milou M. Oosterwijk, Kamlesh Khunti, Pankaj Gupta, Prashanth Patel, Job F.M. van Boven, Hiddo J. Lambers Heerspink, Stephan J.L. Bakker, Gerjan Navis, Roos M. Nijboer, Gozewijn D. Laverman
Journal: Diabetes Care
Diabetes Care 2021;44(6):1419–1425
https://doi.org/10.2337/dc20-2533
Published: 23 April 2021
View articletitled, Biochemical Urine Testing of Medication Adherence and Its Association With Clinical Markers in an Outpatient Population of Type 2 Diabetes Patients: Analysis in the DIAbetes and LifEstyle Cohort Twente (DIALECT)
Open the PDF for Biochemical Urine Testing of Medication Adherence and Its Association With Clinical Markers in an Outpatient Population of Type 2 Diabetes Patients: Analysis in the DIAbetes and LifEstyle Cohort Twente (DIALECT) in another window
Journal Articles

Associations of Diet Quality and All-Cause Mortality Across Levels of Cardiometabolic Health and Disease: A 7.6-Year Prospective Analysis From the Dutch Lifelines Cohort

Free
Petra C. Vinke, Gerjan Navis, Daan Kromhout, Eva Corpeleijn
Journal: Diabetes Care
Diabetes Care 2021;44(5):1228–1235
https://doi.org/10.2337/dc20-2709
Published: 10 May 2020
View articletitled, Associations of Diet Quality and All-Cause Mortality Across Levels of Cardiometabolic Health and Disease: A 7.6-Year Prospective Analysis From the Dutch Lifelines Cohort
Open the PDF for Associations of Diet Quality and All-Cause Mortality Across Levels of Cardiometabolic Health and Disease: A 7.6-Year Prospective Analysis From the Dutch Lifelines Cohort in another window
Journal Articles

Fibroblast Growth Factor 23 and Mortality in Patients With Type 2 Diabetes and Normal or Mildly Impaired Kidney Function

Free
Stanley M.H. Yeung, S. Heleen Binnenmars, Christina M. Gant, Gerjan Navis, Ron T. Gansevoort, Stephan J.L. Bakker, Martin H. de Borst, Gozewijn D. Laverman
Journal: Diabetes Care
Diabetes Care 2019;42(11):2151–2153
https://doi.org/10.2337/dc19-0528
Published: 05 September 2019
View articletitled, Fibroblast Growth Factor 23 and Mortality in Patients With Type 2 Diabetes and Normal or Mildly Impaired Kidney Function
Open the PDF for Fibroblast Growth Factor 23 and Mortality in Patients With Type 2 Diabetes and Normal or Mildly Impaired Kidney Function in another window
Includes: Supplementary data
Journal Articles

Physical Activity in Patients With Type 2 Diabetes: The Case for Objective Measurement in Routine Clinical Care

Free
Nicole Oosterom, Christina M. Gant, Niels Ruiterkamp, Bert-Jan F. van Beijnum, Hermie Hermens, Stephan J.L. Bakker, Gerjan Navis, Miriam M.R. Vollenbroek-Hutten, Gozewijn D. Laverman
Journal: Diabetes Care
Diabetes Care 2018;41(4):e50–e51
https://doi.org/10.2337/dc17-2041
Published: 06 February 2018
View articletitled, Physical Activity in Patients With Type 2 Diabetes: The Case for Objective Measurement in Routine Clinical Care
Open the PDF for Physical Activity in Patients With Type 2 Diabetes: The Case for Objective Measurement in Routine Clinical Care in another window
Journal Articles

Prescribing Quality and Prediction of Clinical Outcomes in Patients With Type 2 Diabetes: A Prospective Cohort Study

Free
Kirsten P.J. Smits, Grigory Sidorenkov, Gerjan Navis, Margriet Bouma, Marianne A. Meulepas, Henk J.G. Bilo, Petra Denig
Journal: Diabetes Care
Diabetes Care 2017;40(7):e83–e84
https://doi.org/10.2337/dc17-0236
Published: 04 May 2017
View articletitled, Prescribing Quality and Prediction of Clinical Outcomes in Patients With Type 2 Diabetes: A Prospective Cohort Study
Open the PDF for Prescribing Quality and Prediction of Clinical Outcomes in Patients With Type 2 Diabetes: A Prospective Cohort Study in another window
Journal Articles

Copeptin, a Surrogate Marker for Arginine Vasopressin, Is Associated With Cardiovascular and All-Cause Mortality in Patients With Type 2 Diabetes (ZODIAC-31)

Open Access
Ineke J. Riphagen, PHARMD, Wendy E. Boertien, MD, Alaa Alkhalaf, MD, Nanne Kleefstra, MD, Ron T. Gansevoort, MD, Klaas H. Groenier, PHD, Kornelis J.J. van Hateren, MD, Joachim Struck, PHD, Gerjan Navis, MD, Henk J.G. Bilo, MD, Stephan J.L. Bakker, MD
Journal: Diabetes Care
Diabetes Care 2013;36(10):3201–3207
https://doi.org/10.2337/dc12-2165
Published: 14 September 2013
View articletitled, Copeptin, a Surrogate Marker for Arginine Vasopressin, Is Associated With Cardiovascular and All-Cause Mortality in Patients With Type 2 Diabetes (ZODIAC-31)
Open the PDF for Copeptin, a Surrogate Marker for Arginine Vasopressin, Is Associated With Cardiovascular and All-Cause Mortality in Patients With Type 2 Diabetes (ZODIAC-31) in another window
Includes: Supplementary data
Journal Articles

Pancreatic β-Cell Dysfunction and Risk of New-Onset Diabetes After Kidney Transplantation

Open Access
Dorien M. Zelle, MSC, Eva Corpeleijn, PHD, Jolijn Deinum, MSC, Ronald P. Stolk, MD, PHD, Rijk O.B. Gans, MD, PHD, Gerjan Navis, MD, PHD, Stephan J.L. Bakker, MD, PHD
Journal: Diabetes Care
Diabetes Care 2013;36(7):1926–1932
https://doi.org/10.2337/dc12-1894
Published: 12 June 2013
View articletitled, Pancreatic β-Cell Dysfunction and Risk of New-Onset Diabetes After Kidney Transplantation
Open the PDF for Pancreatic β-Cell Dysfunction and Risk of New-Onset Diabetes After Kidney Transplantation in another window
Journal Articles

Creatinine Excretion Rate and Mortality in Type 2 Diabetes and Nephropathy

Open Access
Steef J. Sinkeler, MD, Arjan J. Kwakernaak, MD, Stephan J.L. Bakker, MD, Shahnaz Shahinfar, MD, Enric Esmatjes, MD, Dick de Zeeuw, MD, Gerjan Navis, MD, Hiddo J. Lambers Heerspink, PHARMD
Journal: Diabetes Care
Diabetes Care 2013;36(6):1489–1494
https://doi.org/10.2337/dc12-1545
Published: 15 May 2013
View articletitled, Creatinine Excretion Rate and Mortality in Type 2 Diabetes and Nephropathy
Open the PDF for Creatinine Excretion Rate and Mortality in Type 2 Diabetes and Nephropathy in another window
Includes: Supplementary data
Journal Articles

Comment on: Ekinci et al. Dietary Salt Intake and Mortality in Patients With Type 2 Diabetes. Diabetes Care 2011;34:703–709

Open Access
Hiddo J. Lambers Heerspink, PHARMD PHD, Arjan Kwakernaak, MD PHD, Dick de Zeeuw, MD PHD, Gerjan Navis, MD PHD
Journal: Diabetes Care
Diabetes Care 2011;34(7):e124–124
https://doi.org/10.2337/dc11-0711
Published: 17 June 2011
View articletitled, Comment on: Ekinci et al. Dietary Salt Intake and Mortality in Patients With Type 2 Diabetes. Diabetes Care 2011;34:703–709
Open the PDF for Comment on: Ekinci et al. Dietary Salt Intake and Mortality in Patients With Type 2 Diabetes. Diabetes Care 2011;34:703–709 in another window